Patent details

Basic Information

Publication number:

EP2089428

PCT Application Number:

PCT/US/2007/022622

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP078529534

PCT Publication Number:

WO/2008/057240

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES

French Title of Invention:

ANTICORPS ANTI-HTNFALPHA CRISTALLISÉS

German Title of Invention:

KRISTALLINE ANTI-HTNFALPHA-ANTIKÖRPER

SPC Number:

Dates

Filing date:

25/10/2007

Grant date:

20/11/2013

EP Publication Date:

20/11/2013

PCT Publication Date:

15/05/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/08/2009

EP B1 Publication Date:

20/11/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/10/2014

Expiration date:

25/10/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/10/2007

 

 

Name:

AbbVie Biotechnology Ltd

Address:

Clarendon House 2, Church Street, HM 11 Hamilton, Bermuda (BM)

Inventor

1

Name:

KOENIGSDORFER Anette

Address:

Germany (DE)

2

Name:

KRAUSE Hans-Juergen

Address:

Germany (DE)

3

Name:

FRAUNHOFER Wolfgang

Address:

United States (US)

4

Name:

GOTTSCHALK Stefan

Address:

Germany (DE)

5

Name:

WINTER Gerhard

Address:

Germany (DE)

6

Name:

BORHANI David W.

Address:

United States (US)

Priority

Priority Number:

855104 P

Priority Date:

27/10/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 16/00;

Filing date	Document type	Number of pages